Venus Remedies shines on winning Manufacturing Leadership Award 2012

18 Sep 2012 Evaluate

Venus Remedies is currently trading at Rs. 276.30, up by 8.50 points or 3.17% from its previous closing of Rs. 267.80 on the BSE.

The scrip opened at Rs. 269.00 and has touched a high and low of Rs. 279.25 and Rs. 268.10 respectively. So far 22,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 308.45 on 11-Sep-2012 and a 52 week low of Rs. 141.05 on 22-Dec-2011.

Last one week high and low of the scrip stood at Rs. 300.55 and Rs. 262.05 respectively. The current market cap of the company is Rs. 269.00 crore.

The promoters holding in the company stood at 34.71% while Institutions and Non-Institutions held 14.54% and 50.76% respectively.

Venus Remedies has won Manufacturing Award for its world class manufacturing and operational excellence at the ‘Industry 2.0 Manufacturing Innovation Conclave 2012’. Being in the highly regulated Pharmaceutical industry, the company’s three manufacturing facilities has 15 national and international GMP certifications to its credit, which includes EUROPEAN-GMP, WHO-GMR GCC-GMP, Latin American GMP (INVIMA) and many more.

Apart from this, the company has won ‘Silver Certificate of Merit’ in the Economic Times’ India Manufacturing Excellence Awards (IMEA), 2011 in recognition and acknowledgment of Venus’s high standards in terms of its manufacturing practices, quality, regulatory approvals, significant investment on its state-of-the-art R&D centre, well equipped facilities and fine infrastructure.

Venus Remedies has a presence in both the branded and generic products segments of the pharmaceutical industry, especially in the critical-care segment. The company with its manufacturing units in Panchkula (Haryana) and Baddi (Himachal Pradesh) manufactures large- and small-volume parenterals, mainly in the antibiotics and oncology segments. The company accesses the European market through its wholly owned subsidiary, VP, based in Germany.

Venus Remedies Share Price

750.00 -13.50 (-1.77%)
09-Dec-2025 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1259.20
Cipla 1499.40
Zydus Lifesciences 920.40
Lupin 2060.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×